Clinical Trial Update: Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed plus Tarceva as salvage therapy in EGFR-overexpressed metastatic colorectal cancer after failure of standard chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)
• Tarceva (erlotinib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Colo-rectal Cancer | Phase 2 | Status: COMPLETED